Artiva Investigational Site Charlotte

Charlotte, North Carolina 28625

1 studies enrolling now · 2 studies all time

What they study most

IIM, Idiopathic Inflammatory Myopathies (IIMs), Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV, Myositis, Refractory Rheumatoid Arthritis (RA), Refractory Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA, SLE, Scleroderma, Sjogren Syndrome, Sjogrens Disease

Studies at this site

• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. — Recruiting now
• AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus — Running, not enrolling